Loading...

bioMérieux S.A.

BMXXYPNK
HealthcareMedical - Specialties
$12.95
$0.00(0.00%)

bioMérieux S.A. BMXXY Peers

See (BMXXY) competitors and their performances in Stock Market.

Peer Comparison Table: Medical - Specialties Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
BMXXY$12.95N/A15.27B32.37$0.40+0.70%
EBOSY$41.94N/A2.11B22.92$1.83N/A
XVIPY$11.45-6.53%360.67MN/AN/AN/A
EBRCZ$0.55N/A203.39M-4.57-$0.12N/A
TRXDW$0.15-11.76%40.09MN/AN/AN/A
NVNBW$1.00N/A17.54M-0.51-$1.95N/A
GWPC$0.00N/A51950.00-0.01-$0.01N/A
SXHHF$0.00+0.00%38133.00-0.01-$0.01N/A
KKUR$0.00N/A8200.00N/AN/AN/A
OMRX$0.00+0.00%5321.00N/A-$0.02N/A
Showing 1 to 10 of 21 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

BMXXY vs EBOSY Comparison

BMXXY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, BMXXY stands at 15.27B. In comparison, EBOSY has a market cap of 2.11B. Regarding current trading prices, BMXXY is priced at $12.95, while EBOSY trades at $41.94.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

BMXXY currently has a P/E ratio of 32.37, whereas EBOSY's P/E ratio is 22.92. In terms of profitability, BMXXY's ROE is +0.10%, compared to EBOSY's ROE of N/A. Regarding short-term risk, BMXXY is more volatile compared to EBOSY. This indicates potentially higher risk in terms of short-term price fluctuations for BMXXY.

Stock Price Comparison

Loading...

Frequently Asked Questions

Meyka LogoMeyka

Meyka is the best Alternative Data platform powered by AI providing research insights for investors

Connect With Us

Legal Disclaimer

The information provided by Meyka AI PTY LTD is for informational and research purposes only and does not constitute financial, investment, or trading advice. Meyka is a research platform, not a financial advisory service. Investing in financial markets involves risks, and past performance does not guarantee future results. Users should conduct their own due diligence, consult with professional financial advisors, and assess their risk tolerance before making investment decisions. Meyka and its operators are not liable for any financial losses incurred from the use of information on this platform. The data provided is derived from publicly available sources and is believed to be reliable but may not always be accurate or up to date. Users should independently verify information and not rely solely on Meyka for financial decisions. By using Meyka, you acknowledge that it does not provide financial advice or recommendations and agree to seek guidance from a qualified financial professional before making any investment decisions.

© 2025 Meyka AI PTY LTD. All rights reserved.